Approach to hematuria ca. 2026 from @ajkd.bsky.social
#Nephpearls #NephSky

Approach to hematuria ca. 2026 from @ajkd.bsky.social
#Nephpearls #NephSky
PRO/CON debate: nonsteroidal (finerenone) vs. steroidal (spironolactone/ eplerenone) mineralocorticoid receptor antagonists in CKD: progress, pragmatism, and remaining uncertainties ca. 2026 from @ckj-era.bsky.social
#Nephpearls #Cardiorenal #NephSky
C3G Glomerulopathy: Mechanistic Targets 🎯 of Potential Novel Therapies from @kdigo.org
#Nephpearls #NephSky
IgA Nephropathy #IgAN: Pathophysiology and Mechanistic Targets 🎯 of Potential Novel Therapies from @kdigo.org
#Nephpearls #NephSky
Select RCTs, informing current management strategies for patients with SA-AKI
#Nephpearls #AKIinICU #NephJC #NephSky
Sepsis-associated AKI (SA-AKI): Pathophysiology
#Nephpearls #AKIinICU
📌 Organ dysfunction during sepsis develops even in the absence of decreased O2 delivery (Hypotension and ischemic injury are not the sole cause)
Sepsis is a syndrome defined by organ dysfunction because of a dysregulated host response to infection
#Nephpearls #AKIinICU #NephSky
📌 Septic shock is a subset of sepsis defined by hypotension requiring vasopressors to maintain an MAP >/= 65 mm Hg and serum lactate >2 mmol/L after resuscitation
Treatment with maximally tolerated RAASi alone does not sufficiently slow the rate of eGFR decline in high-risk patients with IgA nephropathy #IgAN, leaving patients at risk of ESKD ca. 2026 from @asnpublications.bsky.social
#Nephpearls #NephSky
Clinical conditions related to LVADs that may arise during hemodialysis
#Nephpearls #NephSky
Call 📢 for papers: "The Jerry Yee: Clinical Challenges in Diagnosis and Treatment in Nephrology"
#Nephpearls #NephSky
🗓️ Deadline for submissions: 15 October 2026
Impact of proteinuria levels on long-term kidney outcomes in IgA nephropathy: a meta-analysis ca. 2026 from @glomcon.org Rare Kidney Disease journal
#Nephpearls #NephSky
Ten tips for the diagnosis and management of nephrotic syndrome ca. 2026
#Nephpearls #NephSky
Classic course of whole-kidney GFR and UAE according to the natural (proteinuric) pathway of #Diabetic #Kidney Disease (DKD) ca. 2017
#Nephpearls #NephSky
Adults with #IgAN are at greater risk of adverse kidney outcomes versus nonglomerular CKD and substantially higher risks of heart failure and death compared with no CKD ca. 2026 from @KIReports
#Nephpearls #RKDSummit #NephSky
Not all #IgAN therapies are created equal
#Nephpearls #RKDSummit #NephSky
Dipstick hemoglobinuria is associated with histologic markers of active disease in #IgAN and may provide clinically relevant information to complement current assessment of disease activity in #IgAN ca. 2026
#Nephpearls #RKDSummit #NephSky
Microscopic hematuria as a risk factor for #IgAN progression: considering this biomarker in selecting and monitoring patients ca. 2023
#Nephpearls #RKDSummit #NephSky
Targeting B cells in immune-mediated kidney diseases: conclusions from @kdigo.org Controversies Conference ca. 2026
#Nephpearls #RKDSummit #NephSky
Colloids vs Crystalloids
#Nephpearls #AKIinICU #NephSky
Kidney Health Guidance on Cardiovascular-Kidney-Metabolic (CKM) Syndrome ca. 2026 from @asnpublications.bsky.social
#Nephpearls #NephSky #Cardiorenal